Reprint

The Challenges of COVID-19 with Obesity-Related Cancers

Edited by
April 2023
224 pages
  • ISBN978-3-0365-7351-9 (Hardback)
  • ISBN978-3-0365-7350-2 (PDF)

This book is a reprint of the Special Issue The Challenges of COVID-19 with Obesity-Related Cancers that was published in

Biology & Life Sciences
Medicine & Pharmacology
Summary

This reprint emphasizes the perspectives and challenges surrounding COVID-19 and obesity-related cancers, including but not limited to the risk factors of severe COVID-19 in cancer patients; the complications of COVID-19 in cancer patients; the challenges in cancer treatment and surgery; guidelines for cancer care during COVID-19; delayed diagnosis and suboptimal cancer management; the impact of COVID-19 on cancer screening, early diagnosis and cancer presentation; immune response after SARS-CoV-2 infection and vaccination in cancer patients; psychological distress among cancer survivors; telehealth in cancer care; the role of diet and nutraceuticals in the prevention of severe COVID-19 and cancer; and the effects of COVID-19 pandemic on cancer research.

Format
  • Hardback
License
© by the authors
Keywords
COVID-19; neutropenia; G-CSF treatment; respiratory failure; colorectal neoplasms; COVID-19; gastrointestinal neoplasms; immune checkpoint inhibitors; neoplasms; oncogenic viruses; oncolytic virotherapy; post-acute COVID-19 syndrome; reactive oxygen species; tumor escape; COVID-19; SARS-CoV-2; thyroid cancer; differentiated thyroid cancer; COVID-19 severity; inflammation; immunity; oxidative stress; obesity; SARS-Cov-2; COVID-19; oncology; cancer screening; clinical trials; melanoma; COVID-19; management; pandemic; teledermatology; diagnostic delay; immunotherapy; vaccination; lymph adenopathy; cancer; nutraceuticals; supplements; COVID-19; SARS-CoV-2; cancer; colorectal; COVID-19; pandemic; meta-analysis; COVID-19; gynecologic oncology; obesity; SARS-CoV-2; malignancy; cancer; blood cancer; COVID-19; hematologic malignancy; leukemia; lymphoma; multiple myeloma; myelodysplasia; obesity; SARS-CoV-2; breast cancer; COVID-19; cancer care; screening; surgery; psychological distress; cancer; cancer therapies; COVID-19; vaccination; immunogenicity; safety; vaccine hesitancy; obesity; COVID-19; cancer; tumor subtype; mortality; intensive care unit; medico-administrative data; SARS-CoV-2; France; n/a